EP0804576A4 - A novel haemopoietin receptor - Google Patents

A novel haemopoietin receptor

Info

Publication number
EP0804576A4
EP0804576A4 EP95931079A EP95931079A EP0804576A4 EP 0804576 A4 EP0804576 A4 EP 0804576A4 EP 95931079 A EP95931079 A EP 95931079A EP 95931079 A EP95931079 A EP 95931079A EP 0804576 A4 EP0804576 A4 EP 0804576A4
Authority
EP
European Patent Office
Prior art keywords
components
parts
receptor
present
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP95931079A
Other languages
German (de)
French (fr)
Other versions
EP0804576B1 (en
EP0804576A1 (en
Inventor
Douglas James Hilton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Walter and Eliza Hall Institute of Medical Research
Original Assignee
Amrad Operations Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPM7902A external-priority patent/AUPM790294A0/en
Priority claimed from AUPM7901A external-priority patent/AUPM790194A0/en
Application filed by Amrad Operations Pty Ltd filed Critical Amrad Operations Pty Ltd
Publication of EP0804576A1 publication Critical patent/EP0804576A1/en
Publication of EP0804576A4 publication Critical patent/EP0804576A4/en
Application granted granted Critical
Publication of EP0804576B1 publication Critical patent/EP0804576B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention relates generally to novel haemopoietin receptors, or components or parts thereof and to a method for cloning genetic sequences encoding same. More particularly, the subject invention is directed to recombinant or synthetic haemopoietin receptors or components or parts thereof. The receptor molecules or components or parts thereof and their genetic sequences of the present invention are useful in the development of a wide range agonists, antagonists and therapeutics and diagnostic reagents based on ligand interaction with its receptor.
EP95931079A 1994-09-05 1995-09-05 A novel haemopoietin receptor Expired - Lifetime EP0804576B1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AUPM7902A AUPM790294A0 (en) 1994-09-05 1994-09-05 A novel haemopoietin receptor
AUPM7901A AUPM790194A0 (en) 1994-09-05 1994-09-05 A method for cloning haemopoietin receptor genetic sequences
AUPM7901/94 1994-09-05
AUPM7902/94 1994-09-05
PCT/AU1995/000578 WO1996007737A1 (en) 1994-09-05 1995-09-05 A novel haemopoietin receptor

Publications (3)

Publication Number Publication Date
EP0804576A1 EP0804576A1 (en) 1997-11-05
EP0804576A4 true EP0804576A4 (en) 1999-11-17
EP0804576B1 EP0804576B1 (en) 2008-09-03

Family

ID=25644759

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95931079A Expired - Lifetime EP0804576B1 (en) 1994-09-05 1995-09-05 A novel haemopoietin receptor

Country Status (8)

Country Link
US (4) US6274708B1 (en)
EP (1) EP0804576B1 (en)
JP (1) JP3949715B2 (en)
AT (1) ATE407208T1 (en)
CA (1) CA2197873A1 (en)
DE (1) DE69535831D1 (en)
ES (1) ES2316149T3 (en)
WO (1) WO1996007737A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2197873A1 (en) * 1994-09-05 1996-03-14 Douglas James Hilton A novel haemopoietin receptor
US6451523B1 (en) 1994-09-14 2002-09-17 Interneuron Pharmaceuticals, Inc. Detection of a leptin receptor variant and methods for regulating obesity
US6355237B1 (en) 1994-09-14 2002-03-12 Progenitor, Inc. Methods for using the obese gene and its gene product to stimulate hematopoietic development
US5763211A (en) * 1994-09-14 1998-06-09 Progenitor, Inc. Isolated nucleic acid encoding Hu-B1.219, a novel human hematopoietin
US5643748A (en) * 1994-09-14 1997-07-01 Progenitor, Inc. HU-B1.219, a novel human hematopoietin receptor
US6274547B1 (en) 1996-06-14 2001-08-14 Genetics Institute, Inc. Methods comprising the use of human interleukin-11 receptor proteins
DE69535274T2 (en) * 1994-12-22 2007-06-06 Genetics Institute, LLC, Cambridge USE OF HUMAN INTERLEUKIN-11 RECEPTOR
EP0907730B1 (en) * 1995-10-23 2009-10-07 Zenyth Operations Pty Ltd Haemopoietin receptor and genetic sequences encoding same
AU731968B2 (en) * 1996-09-11 2001-04-12 Amrad Operations Pty. Limited A novel haemopoietin receptor and genetic sequences encoding same
AUPO224696A0 (en) * 1996-09-11 1996-10-03 Amrad Operations Pty. Limited A novel haemopoietin receptor and genetic sequences encoding same
AUPO439396A0 (en) 1996-12-24 1997-01-23 Walter And Eliza Hall Institute Of Medical Research, The A method of treatment and prophylaxis
EP1487965A4 (en) 2002-02-25 2006-11-15 Mpex Pharmaceuticals Inc Minicell compositions and methods
AU2003297062A1 (en) * 2002-12-11 2004-06-30 University Of Massachusetts METHOD OF INTRODUCING siRNA INTO ADIPOCYTES

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU651596B2 (en) 1990-06-05 1994-07-28 Immunex Corporation Type II interleukin-1 receptors
US5314899A (en) 1992-03-03 1994-05-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Epibatidine and derivatives, compositions and methods of treating pain
WO1993018047A1 (en) 1992-03-09 1993-09-16 Ludwig Institute For Cancer Research Nucleic acid sequences coding for or complementary to nucleic acid sequences coding for interleukin 9 receptor
CA2197873A1 (en) * 1994-09-05 1996-03-14 Douglas James Hilton A novel haemopoietin receptor
DE69535274T2 (en) * 1994-12-22 2007-06-06 Genetics Institute, LLC, Cambridge USE OF HUMAN INTERLEUKIN-11 RECEPTOR

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CHEREL M ET AL: "MOLECULAR CLONING OF TWO ISOFORMS OF A RECEPTOR FOR THE HUMAN HEMATOPOIETIC CYTOKINE INTERLEUKIN-11", BLOOD, vol. 86, no. 7, 1 October 1995 (1995-10-01), pages 2534 - 2540, XP000566979, ISSN: 0006-4971 *
FOURCIN M. ET AL.: "Involvement of gp130/interleukin-6 receptor transfucing component in interleukin-11 receptor", EUROPEAN JOURNAL OF IMMUNOLOGY, vol. 24, no. 1, January 1994 (1994-01-01), pages 277 - 280, XP002000298 *
NEUHAUS H. ET AL.: "Etl2, a novel putative type-1 citokine receptor expressed during mouse embryogenesis at high levels in skin and cells with skeletogenic potential", DEVELOPMENTAL BIOLOGY, vol. 166, no. 2, 1994, pages 531 - 542, XP002115708 *
YANG Y.C. ET AL: "INTERLEUKIN-11 AND ITS RECEPTOR", BIOFACTORS, vol. 4, no. 1, 1 December 1992 (1992-12-01), pages 15 - 21, XP000566997, ISSN: 0951-6433 *

Also Published As

Publication number Publication date
US7476732B2 (en) 2009-01-13
ES2316149T3 (en) 2009-04-01
JP3949715B2 (en) 2007-07-25
DE69535831D1 (en) 2008-10-16
ATE407208T1 (en) 2008-09-15
US6274708B1 (en) 2001-08-14
EP0804576B1 (en) 2008-09-03
EP0804576A1 (en) 1997-11-05
CA2197873A1 (en) 1996-03-14
JPH10505068A (en) 1998-05-19
US20060051842A1 (en) 2006-03-09
US7002000B1 (en) 2006-02-21
HK1004411A1 (en) 1998-11-27
WO1996007737A1 (en) 1996-03-14
US20030149236A1 (en) 2003-08-07

Similar Documents

Publication Publication Date Title
EP0907730A4 (en) Haemopoietin receptor and genetic sequences encoding same
EP0804576A4 (en) A novel haemopoietin receptor
DK0760857T5 (en) Receptor for oncostatin M
EP0577605A4 (en)
EP0590030A4 (en) A novel receptor-type tyrosine kinase and use thereof
PT915974E (en) MODIFIED TIE-2 RECEIVER LIGANDS
GB2286398B (en) Human metabotropic glutamate receptors,nucleic acids encoding same and uses thereof
EP0873361A4 (en) NUCLEAR RECEPTOR LIGANDS AND LIGAND BINDING AREAS
DE69323765D1 (en) MAMMAL RECEPTORS FOR INTERLEUKIN 10 (IL-10)
NO995182D0 (en) Mammalian cytokine-like factor 7
ATE290595T1 (en) GAMMA-HEREGULIN
WO2002012345A3 (en) Soluble zcytor 11 cytokine receptors
NO20001668D0 (en) Use of a DNA fragment, as well as complementary chains, derivatives and parts thereof
EP0628054A4 (en) CAR RECEPTORS, RELATED MOLECULES AND METHODS OF OBTAINING SAME.
WO1998011225A3 (en) A novel haemopoietin receptor and genetic sequences encoding same
EP1141237A4 (en) PTH RECEPTOR AND SCREENING TEST USING THE SAME
AU7017494A (en) Purified mammalian flt3 ligands and agonists and antagonists thereof
ATE332974T1 (en) IL-1/TNF-ALPHA-ACTIVATED KINASE (ITAK), AND METHOD FOR THE PRODUCTION AND USE THEREOF
CA2180957A1 (en) Cloning and recombinant production of crf receptor(s)
ATE180788T1 (en) POLYPEPTIDES HAVING HUMAN DOPAMINERGIC RECEPTOR ACTIVITY, THEIR CODING NUCLEIC ACID SEQUENCES AND USE OF THESE POLYPEPTIDES
IL141858A0 (en) Diagnostic method for detecting disturbances of the pancreas
NO940797L (en) Receptor derivatives having binding sites for human rhinovirus

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19970401

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 19991006

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20020711

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REF Corresponds to:

Ref document number: 69535831

Country of ref document: DE

Date of ref document: 20081016

Kind code of ref document: P

RAP2 Party data changed (patent owner data changed or rights of a patent transferred)

Owner name: THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RES

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080903

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20081127

Year of fee payment: 14

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080903

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20081201

Year of fee payment: 14

NLV1 Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080903

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20081129

Year of fee payment: 14

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2316149

Country of ref document: ES

Kind code of ref document: T3

Ref country code: GB

Ref legal event code: 732E

Free format text: REGISTERED BETWEEN 20090305 AND 20090311

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080930

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20081128

Year of fee payment: 14

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20090203

REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1004411

Country of ref document: HK

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20081126

Year of fee payment: 14

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080905

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080903

26N No opposition filed

Effective date: 20090604

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080930

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080930

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20081203

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20090905

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20100531

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080905

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20090930

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20100401

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20081204

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20090905

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20090905

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20110708

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20110628

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20090906